4-DMAP 250mg/5ml Injektionslösung und Minirin Parenteral 4μgg Injektionslösung 1ml

Data and Resources

• Anlage 10_Lieferschein.docDOC
  Explore

  • More information
  • Go to resource
• Anlage 4_Beiblatt AM.pdfPDF
  Explore

  • More information
  • Go to resource
• Anlage 7_TS QMA.pdfPDF
  Explore

  • More information
  • Go to resource
• Anlage 9_Staatenliste 2022.pdfPDF
  Explore

  • More information
  • Go to resource
• B-S498-022024.xlsxXLSX
  Explore

  • More information
  • Go to resource
• B-T503-012024.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V034-062023.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V039-022021.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V039a-072023.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V040.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V043-092021.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V045-022019.pdfPDF
  Explore

  • More information
  • Go to resource
• B-V050-022022.pdfPDF
  Explore

  • More information
  • Go to resource
• B114-102012.pdfPDF
  Explore

  • More information
  • Go to resource
• B123-102012.pdfPDF
  Explore

  • More information
  • Go to resource
• B124-012022.pdfPDF
  Explore

  • More information
  • Go to resource
• BE2DTQG130_VM 4-DMAP 250mg_5ml Inj.lsg. u....PDF
  Explore

  • More information
  • Go to resource
• Eigenerklärung VO-2022-833.pdfPDF
  Explore

  • More information
  • Go to resource
• Leistungsverzeichnis.aidfAIDF
  Explore

  • More information
  • Go to resource
• Leistungsverzeichnis.pdfPDF
  Explore

  • More information
  • Go to resource
• Meta.jsonJSON
  Explore

  • More information
  • Go to resource
• VOL_B.pdfPDF
  Explore

  • More information
  • Go to resource
• ZVB-BMVg.pdfPDF
  Explore

  • More information
  • Go to resource
• _Hinweise von der e-Vergabe.txtTXT
  Explore

  • More information
  • Go to resource